Quest Laboratories Share Price Target 2025, 2026, 2030, 2040, 2050

Quest Laboratories makes a variety of medicines, which include generic drugs, branded medicines. They make medicines for malaria and pain. The company’s main factory is in Dhar, Madhya Pradesh, and they have a lab to test their products. It works in 12 states and 2 union territories in India and also supplies medicines to hospitals, makes products for other companies, and exports them. The company does well financially.

What is Quest Laboratories Ltd NSE: QUESTLAB?

Quest Laboratories was established in 1996 and is located in Mumbai, India. It is a well-known company that provides medical testing and diagnostic services. The company was started by Dr. Sandeep Tiwari. It works in the healthcare field, offering a variety of tests that help doctors diagnose and manage different health problems. It plays an important role in the healthcare system by making sure that patients and doctors get fast, reliable, and trustworthy test results when they need them. They make a variety of medicines, which include generic drugs, branded medicines.

Share Price Target Tomorrow

The stock has shown very volatile movement since it was listed on the stock market. After listing, it reached its all-time high price, but the price could not be sustained there and fell. After recording its lowest price till now, the price slowly recovered, and at the current time, the stock is again near its all-time low price. Well, for the buying opportunity, it could be better if it breaks its all-time high price, as the stock has not shown any strong momentum till now.

Day	Minimum Price (Rs)	Maximum Price (Rs)
Tomorrow	-1.87	+2.45

Quest Laboratories share price Target 2025

In 1994, the owner of this company started his business called ABC Pharmaceuticals. The business grew quickly, so in 1995, he started a second company, ABC Herbal Formulations. Both companies did well and then created over 100 brands and earned good money. In 1998, he registered the business as Quest Laboratories and got permission to make liquid medicines, ointments, and other external products. The company kept growing, adding tablets and powders in 2004 and introducing Oral Dry Syrups in 2008, and by the time the comapny became a big brand. In 2025, its share price target would be ₹170.32, as per our analysis.

By our prediction, its share price would be between ₹85.10 and ₹170.32 in 2025.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	85.10	170.32

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	118.00	157.10
February	137.25	160.00
March	94.15	136.90
April	93.45	138.57
May	88.14	140.11
June	85.10	144.15
July	94.23	146.35
August	98.64	149.66
September	105.74	153.24
October	114.54	157.64
November	120.15	162.54
December	124.35	170.32

Quest Laboratories share price Target 2026

It has WHO GMP Certification. The company makes a variety of products like liquid medicines, powders, tablets, ointments, and external liquids. With many product licenses, it produces large quantities of tablets, syrups, ointments, and ORS pouches every day and is adding more products. The company sells medicines across India and is also growing its export business. It works with several medical corporations and has recently started in Bihar and Jharkhand. It is known for making medicines for conditions like infections, malaria, inflammation, breathing problems, diabetes, and more. In 2026, its share price target would be ₹251.15, as per our prediction.

Its share price would be between ₹124.35 to ₹251.15 in 2026, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	124.35	251.15

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	124.35	174.74
February	127.18	177.64
March	129.64	180.57
April	134.34	188.41
May	145.36	191.34
June	155.25	193.54
July	158.25	198.64
August	160.54	210.57
September	180.33	221.74
October	183.35	227.62
November	208.35	239.64
December	210.58	251.15

Share price Target 2027

The company has a well-equipped lab with modern machines like FTIR, UV, HPLC, GC, Dissolution, and other testing tools. All product testing is done in their lab. The team includes more than 20 experienced professionals. They monitor, ensuring they follow WHO, GMP, and GLP guidelines. They are responsible for managing documents, overseeing production, and ensuring the quality of every product made in the lab. In 2027, its share price target would be ₹329.80, as per our analysis.

By our prediction, its share price would be between ₹210.58 to ₹329.80 in 2027.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	210.58	329.80

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	210.58	257.54
February	219.74	264.35
March	227.35	270.21
April	223.64	273.54
May	227.35	275.66
June	225.15	278.35
July	229.35	281.45
August	235.25	283.34
September	244.34	286.34
October	256.74	290.25
November	260.64	300.45
December	275.34	329.80

Share price Target 2028

The pharmaceutical industry is growing fast, and its importance has been clearly shown during the COVID-19 pandemic. The company plans to set up a new production line for injectable medicines, mainly for cancer treatment. This will include liquid and dry injections, using modern technology to make sure the process is safe and efficient. The new facility will be built in a 14,000-square-foot space in the plant, allowing the company to enter markets in South Africa, South Asia, and other developing countries quickly. In 2028, its share price target would be ₹406.75, as per our analysis.

By our prediction, its share price would be between ₹275.34 to ₹406.75 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	275.34	406.75

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	275.34	334.80
February	278.54	340.57
March	290.64	348.34
April	310.15	353.41
May	314.38	359.15
June	320.54	364.25
July	331.51	367.31
August	338.32	372.34
September	342.24	376.34
October	346.54	387.31
November	355.64	390.15
December	377.64	406.75

Share price Target 2029

The company makes a variety of medicines, including antibiotics, malaria treatments, pain reliever drugs, medicines for nausea, respiratory treatments, diabetes drugs, antidepressants, and more. These products are sold under the name Quest Laboratories. The company offer both prescription and in-lab-made medicines in different forms like tablets, liquids, powders, ointments, and other external liquids. In 2029, its share price target would be ₹491.45, as per our prediction.

Its share price would be between ₹ 377.64 and ₹491.45 in 2029, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	377.64	491.45

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	377.64	410.41
February	378.54	414.64
March	383.64	418.14
April	387.31	421.24
May	392.47	427.64
June	395.45	430.31
July	392.34	437.15
August	397.15	445.54
September	410.41	458.36
October	424.64	570.64
November	431.57	579.64
December	449.64	491.45

Quest Laboratories share price Target 2030

It usually makes several types of products based on what people want. The Company also has a flexible system that allows it to make different products using different methods. This helps them quickly adjust to changes in what people want. The Company also has everything needed to develop new products, test them, and make sure they’re of good quality, so they can create cost-effective processes fast. The Company has an ISO 9001:2015 certification, which means it follows high-quality standards. In 2030, its share price target would be ₹573.55, as per our analysis.

By our prediction, its share price would be between ₹449.64 and ₹573.55 in 2030.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	449.64	573.55

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	449.64	495.87
February	452.42	500.15
March	468.24	509.64
April	482.25	517.64
May	487.76	521.34
June	498.35	529.21
July	504.32	534.25
August	510.54	540.65
September	518.35	549.64
October	522.54	554.75
November	530.54	560.54
December	541.25	573.55

Share price Target 2040

It regularly gets orders from both private companies and government agencies. Over the past few years, the company has won government contracts and worked with important state and central government organisations. It operates in twelve states and two union territories, including Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana, and Bihar. By the end of 2023, the company had 83 employees. In 2040, its share price target would be ₹1378.20, as per our prediction.

Its share price would be between ₹1260.44 to ₹1378.20in 2040, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	1260.44	1378.20

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1260.44	1287.37
February	1265.15	1298.65
March	1268.66	1308.62
April	1270.27	1313.34
May	1274.64	1317.31
June	1278.20	1322.40
July	1284.31	1329.72
August	1287.20	1338.31
September	1290.50	1340.54
October	1297.32	1348.32
November	1310.54	1355.31
December	1325.36	1378.20

Share price Target 2050

The company has shown growth in income and profits over the past few years, with better profit margins. Its earnings and return on equity show that the company is financially strong. The share price seems to be fairly priced, meaning it may not be a great deal. The company has not paid any dividends yet, but plans to do so based on future performance. In 2050, its share price target would be ₹2330.74, as per our analysis.

By our prediction, its share price would be between ₹2206.48 and ₹2330.74 in 2050.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	2206.48	2330.74

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	2206.48	2249.65
February	2214.25	2261.57
March	2218.32	2269.40
April	2221.56	2274.67
May	2224.67	2278.69
June	2228.34	2284.31
July	2235.67	2287.64
August	2247.34	2290.25
September	2255.64	2300.15
October	2276.54	2313.54
November	2280.54	2321.32
December	2294.12	2330.74

Should I buy Quest Laboratories stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	85.10	170.32
2026	124.35	251.15
2027	210.58	329.80
2028	275.34	406.75
2029	377.64	491.45
2030	449.64	573.55
2040	1260.44	1378.20
2050	2206.48	2330.74

The company is doing well financially, making more products, and expanding into new markets. It also has good partnerships with the government and private companies. But the stock has been up and down since it started trading, and while it is improving, it hasn’t shown strong growth yet. If you’re okay with some price changes and want to hold the stock for a long time, it could be a good option.

Quest Laboratories earnings results

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales +	30	59	62	83	84
Expenses +	29	53	54	67	67
Operating Profit	1	6	8	16	18
OPM %	5%	11%	13%	19%	21%
Other Income +	0	0	0	0	1
Interest	0	0	1	1	1
Depreciation	0	0	1	1	1
Profit before tax	1	6	7	14	17
Tax %	18%	29%	28%	30%
Net Profit +	1	4	5	10	12
EPS in Rs	—	—	—	8.45	8.05
Dividend Payout %	0%	0%	0%	0%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
—	6.69	—	49.51	6.30	0.54%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Quest Laboratories Ltd	19.02	6.69	—
Sun Pharmaceutical Industries Ltd	43.88	6.26	0.77%
Cipla Ltd	29.69	4.57	0.86%
Torrent Pharmaceuticals Ltd	66.50	16.07	0.86%

Is Quest Laboratories stock good to buy? (bull case & bear case)

Bull Case:

• There’s strong demand for health and lab testing.
• The company is doing well financially with good income and low debt.
• It has a great track record, with a 45.5% return on equity (ROE) over the last 3 years.

Bear Case:

• The company is reporting repeated profits, but it is not paying out dividends
• Working capital days have increased from 46.3 days to 73.8 days

Conclusion

The company is growing, making good money, and expanding its business in India and other countries. Even though its stock price has been a bit up and down, its focus on quality medicines, working with the government, and plans to make cancer treatments in the future make it a good choice for long-term investors. The stock price is unstable, and the company doesn’t pay dividends yet, so it might not be right for people looking for quick returns. But if you’re okay with waiting and holding the stock, it could be a good investment.

FAQs